FDA Draft Guidance Offers Recommendations to Biologics Makers on Submitting Electronic LDRs

Drug Industry Daily
A A
Biological manufacturers should submit their lot distribution reports (LDRs) using the same electronic messaging standard as those used for drug registration and labeling content of BLAs, says a new draft guidance on LDR electronic submissions.

To View This Article:

Login

Subscribe To Drug Industry Daily